Jennifer Gudeman
Chief Tech/Sci/R&D Officer bij AVADEL PHARMACEUTICALS PLC
Actieve functies van Jennifer Gudeman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AVADEL PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 07-12-2020 | - |
Loopbaan van Jennifer Gudeman
Eerdere bekende functies van Jennifer Gudeman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01-01-2003 | - |
Opleiding van Jennifer Gudeman
St. Louis College of Pharmacy | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Ierland | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AVADEL PHARMACEUTICALS PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Jennifer Gudeman
- Ervaring